Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
71.92
+2.22 (3.18%)
Jun 30, 2026, 11:34 AM EDT - Market open
Moderna Revenue
Moderna had revenue of $389.00M in the quarter ending March 31, 2026, with 260.19% growth. This brings the company's revenue in the last twelve months to $2.23B, down -29.97% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%.
Revenue (ttm)
$2.23B
Revenue Growth
-29.97%
P/S Ratio
12.43
Revenue / Employee
$473,404
Employees
4,700
Market Cap
28.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | -1.29B | -39.93% |
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 5.70B |
| Incyte | 5.36B |
| Jazz Pharmaceuticals | 4.44B |
| Alnylam Pharmaceuticals | 4.29B |
| Genmab | 3.90B |
| BioNTech SE | 3.23B |
| Royalty Pharma | 2.44B |
| Ascendis Pharma | 998.25M |
MRNA News
- 4 hours ago - The 20 best-performing stocks in the S&P 500 for the first half of 2026 - Market Watch
- 3 days ago - Moderna stock soars as cancer pipeline and CAR-T push ignite optimism - Invezz
- 3 days ago - Healthcare stocks have become a haven for investors ditching tech - Market Watch
- 3 days ago - Why Moderna (MRNA) Stock Is Soaring Today – June 26, 2026 - TipRanks
- 3 days ago - Moderna rises 14.2% - TheFly
- 3 days ago - Why Moderna Stock Is Soaring and Leading the S&P 500 Today - Barrons
- 4 days ago - Moderna rises 8.7% - TheFly
- 4 days ago - Moderna price target raised to $77 from $69 at Piper Sandler - TheFly